185 related articles for article (PubMed ID: 17598110)
1. Imaging of tumour hypoxia using PET and 18F-labelled tracers: biology meets technology.
Grönroos T; Minn H
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1563-5. PubMed ID: 17598110
[No Abstract] [Full Text] [Related]
2. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
3. Modelling and simulation of the influence of acute and chronic hypoxia on [18F]fluoromisonidazole PET imaging.
Mönnich D; Troost EG; Kaanders JH; Oyen WJ; Alber M; Thorwarth D
Phys Med Biol; 2012 Mar; 57(6):1675-84. PubMed ID: 22398239
[TBL] [Abstract][Full Text] [Related]
4. Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.
Reischl G; Dorow DS; Cullinane C; Katsifis A; Roselt P; Binns D; Hicks RJ
J Pharm Pharm Sci; 2007; 10(2):203-11. PubMed ID: 17706178
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole.
Lee ST; Scott AM
Semin Nucl Med; 2007 Nov; 37(6):451-61. PubMed ID: 17920352
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia imaging agents labeled with positron emitters.
Hoigebazar L; Jeong JM
Recent Results Cancer Res; 2013; 194():285-99. PubMed ID: 22918765
[TBL] [Abstract][Full Text] [Related]
7. [Technical Approaches for Quantitative Treatment Responses Using 18F-FDG PET].
Miwa K; Miyaji N; Umeda T; Murata T; Wagatsuma K; Sasaki M
Igaku Butsuri; 2015; 35(1):30-8. PubMed ID: 26753394
[TBL] [Abstract][Full Text] [Related]
8. [Fluorinated analogs of nucleosides and fluorinated tracers of gene expression for positron emission tomography].
Couturier O; Chatal JF; Hustinx R
Bull Cancer; 2004 Sep; 91(9):695-703. PubMed ID: 15544995
[TBL] [Abstract][Full Text] [Related]
9. Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles.
Peeters SG; Zegers CM; Yaromina A; Van Elmpt W; Dubois L; Lambin P
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):39-57. PubMed ID: 25517080
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography.
Wijsman R; Kaanders JH; Oyen WJ; Bussink J
Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):244-56. PubMed ID: 24045621
[TBL] [Abstract][Full Text] [Related]
11. PET imaging of tumour hypoxia.
Padhani A
Cancer Imaging; 2006 Oct; 6(Spec No A):S117-21. PubMed ID: 17114063
[TBL] [Abstract][Full Text] [Related]
12. [Current Status and Prospects on PET Radiopharmaceuticals for Radiotherapy].
Yoshimoto M
Igaku Butsuri; 2015; 35(1):10-5. PubMed ID: 26753391
[TBL] [Abstract][Full Text] [Related]
13. [Current trends in using PET radiopharmaceuticals for diagnostics in oncology].
Adam J; Kadeřávek J; Kužel F; Vašina J; Rehák Z
Klin Onkol; 2014; 27 Suppl 1():S129-36. PubMed ID: 24945550
[TBL] [Abstract][Full Text] [Related]
14. Fluorinated tracers for imaging cancer with positron emission tomography.
Couturier O; Luxen A; Chatal JF; Vuillez JP; Rigo P; Hustinx R
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1182-206. PubMed ID: 15241631
[TBL] [Abstract][Full Text] [Related]
15. PET tracers in musculoskeletal disease beyond FDG.
Wieder HA; Pomykala KL; Benz MR; Buck AK; Herrmann K
Semin Musculoskelet Radiol; 2014 Apr; 18(2):123-32. PubMed ID: 24715445
[TBL] [Abstract][Full Text] [Related]
16. Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy.
Busk M; Horsman MR; Jakobsen S; Keiding S; van der Kogel AJ; Bussink J; Overgaard J
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1202-12. PubMed ID: 18313528
[TBL] [Abstract][Full Text] [Related]
17. A robotic synthesis of [18F]fluoromisonidazole ([18F]FMISO).
Chang CW; Chou TK; Liu RS; Wang SJ; Lin WJ; Chen CH; Wang HE
Appl Radiat Isot; 2007 Jun; 65(6):682-6. PubMed ID: 17379530
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive PET and SPECT imaging of tissue hypoxia using isotopically labeled 2-nitroimidazoles.
Koch CJ; Evans SM
Adv Exp Med Biol; 2003; 510():285-92. PubMed ID: 12580442
[TBL] [Abstract][Full Text] [Related]
19. PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls.
Shields AF
J Nucl Med; 2003 Sep; 44(9):1432-4. PubMed ID: 12960188
[No Abstract] [Full Text] [Related]
20. Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio.
Lehtiö K; Oikonen V; Nyman S; Grönroos T; Roivainen A; Eskola O; Minn H
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):101-8. PubMed ID: 12483416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
